Literature DB >> 14504083

Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages.

Akihiro Konno1, Taizo Wada, Shepherd H Schurman, Elizabeth K Garabedian, Martha Kirby, Stacie M Anderson, Fabio Candotti.   

Abstract

Somatic mosaicism because of in vivo reversion has been recently reported in a small number of patients affected with Wiskott-Aldrich syndrome (WAS). Flow cytometry analysis of WAS protein (WASP) expression has shown that these patients carried revertant cells only among T lymphocytes. Here, we have used high-resolution capillary electrophoresis to analyze genomic DNA from highly purified cells of one of these patients and detected revertant sequences also within the B-cell fraction. The demonstration of revertant cells among both T and B lymphocytes in this patient is consistent with the reversion event having occurred in a common lymphoid progenitor. However, although WASP-expressing T cells showed selective advantage and were readily detectable in the periphery of the mosaic patient, revertant B lymphocytes remained below the detection threshold of flow cytometry. These findings suggest that, contrary to T cells, differentiation and survival of B lymphocytes is minimally dependent on WASP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504083     DOI: 10.1182/blood-2003-05-1739

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

Review 2.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

3.  Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.

Authors:  Toru Uchiyama; Marsilio Adriani; G Jayashree Jagadeesh; Adam Paine; Fabio Candotti
Journal:  Mol Ther       Date:  2012-01-03       Impact factor: 11.454

Review 4.  WASP: a key immunological multitasker.

Authors:  Adrian J Thrasher; Siobhan O Burns
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

5.  Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells.

Authors:  Alexander Astrakhan; Hans D Ochs; David J Rawlings
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

6.  Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.

Authors:  Brian R Davis; Fabio Candotti
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 7.  Somatic genetic rescue in Mendelian haematopoietic diseases.

Authors:  Patrick Revy; Caroline Kannengiesser; Alain Fischer
Journal:  Nat Rev Genet       Date:  2019-06-11       Impact factor: 53.242

Review 8.  Development of lentiviral gene therapy for Wiskott Aldrich syndrome.

Authors:  Anne Galy; Maria-Grazia Roncarolo; Adrian J Thrasher
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

Review 9.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

Review 10.  Gene therapy for severe combined immunodeficiency: are we there yet?

Authors:  Marina Cavazzana-Calvo; Alain Fischer
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.